EPRX: EUPRAXIA PHARMACEUTICALS INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-13 | Fell below 5% | MANCHESTER MANAGEMENT COMPANY, LLC | 4.50% | SEC |
Institutional ownership (Q2 2026)
67 institutions reported holding $139.33M of EUPRAXIA PHARMACEUTICALS INC. on Form 13F (54 the quarter before). 16 opened a new position and 5 sold out. Shares held by institutions: +13%.
| Largest holders | Shares | Value |
|---|---|---|
| Affinity Asset Advisors, LLC | 1,650,000 | $10.91M |
| Balyasny Asset Management L.P. | 1,350,015 | $8.92M |
| Vivo Capital, LLC | 1,350,000 | $8.92M |
| SCOTIA CAPITAL INC. | 1,343,726 | $8.78M |
| PFM Health Sciences, LP | 1,210,661 | $8.00M |
| GREAT POINT PARTNERS LLC | 1,200,000 | $7.93M |
| Jupiter Topco LLC | 1,046,000 | $6.85M |
| Rubric Capital Management LP | 867,424 | $5.73M |
| Ikarian Capital, LLC | 809,741 | $5.35M |
| Woodline Partners LP | 746,864 | $4.94M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.